KospicyKorean filings in English
Filings / HEM Pharma Inc.

Acquisition of Shares in Another Company

HEM Pharma Inc. · 타법인주식및출자증권취득결정

8-KKOSDAQ · 376270 Filed 2026-11-20Korean original on DART

English form view 62% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Decision to acquire shares and equity securities of another company

1. IssuerCompany name (nationality)주식회사 나이스헬스디바이스코퍼레이션CEO문성식
Capital (KRW)3,300,000,000Relationship to CompanySubsidiary
Total Shares Issued (shares)660,000Principal business기타금융투자업
-New shares acquired via 3-party allotment within last 6 monthsNo
2. Acquisition DetailsShares acquired (shares)280,000
Acquisition Amount (KRW)2,184,000,000
Equity (KRW)6,244,874,634
% of Equity34.97
Large EnterpriseN/A
3. Shares Held and Ownership Ratio After AcquisitionShares Owned (shares)660,000
Ownership (%)100
4. Acquisition Method현금취득 - 상환전환우선주 280,000주(구주취득)
5. Purpose of Acquisition지배력 강화 및 사업 시너지 극대화를 위한 기업가치 제고
6. Planned Acquisition Date2026-12-09
7. Subject to material event report on asset acquisitionNo
-Total assets at latest fiscal year-end (KRW)51,834,280,448Acquisition price / total assets (%)4.21
8. Backdoor ListingNo
-Plans for third-party allotment capital increase etc. within 6 months (3)No
9. Issuer (other company) meets backdoor listing criteriaNo
10. Board Resolution Date (Decision Date)2026-11-20
- Outside Directors PresentPresent (persons)1
Absent (persons)2
- Auditor (Audit Committee Member) AttendancePresent
11. Subject to KFTC FilingN/A
12. Put Option Agreements, etc.No
- Contract Details-
13. Other Matters Relevant to Investment Decisions1. 상기 '2. 취득내역'의 자기자본은 당사의 최근사업연도말(2025. 12. 31) 한국채택국제회계기준(K-IFRS)에 따라 작성한 연결재무제표 기준 자기자본에 공시사유 발생일까지 당해 사업연도의 자본금 및 자본잉여금의 증감액을 반영한 수치입니다. 2. 상기 '3. 취득후 소유주식수 및 지분비율'은 본 거래로 취득할 주식수 및 지분율이며, 당사는 본 거래에 따라 발행회사의 지배력을 취득합니다. 3. 상기 '6. 취득예정일자'는 거래 완결(인수대금 납입 완료일) 예정일 입니다. 4. 발행회사는 2026년도 신설법인으로 요약 재무상황 기재를 생략합니다.

[Issuer's Summary Financial Position]

(Unit: KRW m)

CategoryTotal AssetsTotal LiabilitiesTotal EquityPaid-in CapitalRevenueNet Income
Current year------
Prior Year------
Two Years Prior------

[Counterparty Information]

1. Personal Information
- General Information
Name (Entity Name)NationalityAddress (Head Office) [Town/District Level Only]Date of Birth (Business Registration No., etc.)
한재익Republic of Korea서울특별시 서초구 서초동710930
Occupation (business)(주)오션엔지니어링 대표이사
- Largest Shareholder, CEO, Representative Executive Officer and Financial Condition (if counterparty is a corporation)
CategoryNameNumber of SharesOwnership (%)
Largest Shareholder---
CEO---
(Unit: KRW m)
Relevant fiscal year-Fiscal year-end-
Total Assets-Paid-in Capital-
Total Liabilities-Revenue-
Total Equity-Net income (loss)-
External Auditor-Business suspendedNo
Audit Opinion-Business closedNo
2. Relationship with Counterparty
1. Relationship between Company and Counterparty-
2. Relationship between Company's Largest Shareholder/Officers and CounterpartyNameRelationship with Counterparty
---
3. Transactions in Past 3 Years (excl. Ordinary Transactions)
CategoryTransaction Details
Current year2026.06.19 (주)나이스헬스디바이스코퍼레이션 주식양수도 380,000주 거래금액: 1,920,252,055원
Prior Year-
Two Years Prior-